Evidence map›Paper›PMID 42007697›Full record

ArticleMicrobiology spectrum2026

6-methylflavone exerts selective antimycobacterial activity with membrane energetics disruption and demonstrates therapeutic potential against

Jaehun Oh, Jeong-Won Shin, Hyejun Seo, Hyung-Jun Kim, Nam-Jung Kim, Bum-Joon Kim

Abstract read
In one paragraph

Article in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jaehun Oh *Department of Microbiology and Immunology, College of Medicine, Seoul National University, Seoul, Republic of Korea.ORCID 0009-0004-8659-8636
Jeong-Won Shin *College of Pharmacy, Kyung Hee University, Seoul, Republic of Korea.
Hyejun SeoDepartment of Microbiology and Immunology, College of Medicine, Seoul National University, Seoul, Republic of Korea.
Hyung-Jun KimDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea.ORCID 0000-0003-1984-8864
Nam-Jung KimCollege of Pharmacy, Kyung Hee University, Seoul, Republic of Korea.ORCID 0000-0003-3991-5470
Bum-Joon KimDepartment of Microbiology and Immunology, College of Medicine, Seoul National University, Seoul, Republic of Korea.ORCID 0000-0003-0085-6709

Funding

Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education RS-2025-00553721SNUBH Research Fund 16-2023-0011
6 · The paper itself

Abstract

Treatment of nontuberculous mycobacteria (NTM) diseases, especially IMPORTANCE: Despite the increasing global incidence of nontuberculous mycobacterial (NTM) diseases, effective treatment regimens remain limited. In particular,

Indexed as

Anti-Bacterial AgentsCell MembraneFlavonesMycobacterium abscessusMycobacterium Infections, NontuberculousAmikacinAnimalsCell LineClarithromycinFemaleMiceMice, Inbred BALB C6-methylflavoneAmikacinAnti-Bacterial AgentsClarithromycinFlavones6-methylflavoneflavonoidsmembrane energetics disruptorsMycobacterium abscessusnarrow-spectrum antibioticsnontuberculous mycobacteria

Identifiers

PMID42007697
PMCPMC13228053

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.